Cargando…
How to choose a point‐of‐care testing for troponin
BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selec...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370753/ https://www.ncbi.nlm.nih.gov/pubmed/32222055 http://dx.doi.org/10.1002/jcla.23263 |
_version_ | 1783561033094266880 |
---|---|
author | Lin, Ya‐hui Zhang, Yang Liu, Yu‐tao Cui, Kai Kang, Jin‐suo Zhou, Zhou |
author_facet | Lin, Ya‐hui Zhang, Yang Liu, Yu‐tao Cui, Kai Kang, Jin‐suo Zhou, Zhou |
author_sort | Lin, Ya‐hui |
collection | PubMed |
description | BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selection comparing them to the central laboratory, seven POC devices commonly employed by emergency department were evaluated. METHODS: Firstly, we reviewed all devices package inserts. Secondly, we evaluated several POC cTn assays for imprecision, linearity, and correlation with central laboratory assays according to CLSI EP protocols. The linear regression analyses were performed only for the detectable concentrations. Five cTnI devices (Alere Triage, BioMerieux Vidas, Mitsubishi Pathfast, ReLIA TZ‐301, and Radiometer AQT90) were evaluated against a contemporary cTnI assay (Beckman Access II Accu TnI). Two cTnT assays (Radiometer AQT90 and Roche Cobas h232) were compared to a high‐sensitivity (hs) cTnT method (Roche Cobas e601). RESULTS: For cTn levels around the 99th percentile upper reference limits (URLs) of the comparator assays, imprecision could not be assessed for the Alere, BioMerieux, and Cobas h232 as they gave undetectable readings due to a lack of assay sensitivity. Imprecision (CV) was unacceptably high for the ReLIA (33.3%). On account of this precision metric, these four assays were deemed unsuitable. Regression analyses showed acceptable linearity for all the POC devices. The correlation coefficients for ReLIA, BioMerieux, Cobas h232, and Radiometer cTnT were >0.95. Unlike the cTnT devices, the cTnI assays employ different capture and detection antibodies leading to non‐commutable results. The POC cTn results were concordant with their comparator—Radiometer cTnT 90%, Pathfast cTnI 85%, and Radiometer cTnI 75%. CONCLUSION: Our study provides the procedure and essential data to guide selection of a POC cTn device. Of the point‐of‐care devices, methods evaluated Radiometer AQT90 (cTnI and cTnT) and Pathfast might be considered. |
format | Online Article Text |
id | pubmed-7370753 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73707532020-07-21 How to choose a point‐of‐care testing for troponin Lin, Ya‐hui Zhang, Yang Liu, Yu‐tao Cui, Kai Kang, Jin‐suo Zhou, Zhou J Clin Lab Anal Research Articles BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selection comparing them to the central laboratory, seven POC devices commonly employed by emergency department were evaluated. METHODS: Firstly, we reviewed all devices package inserts. Secondly, we evaluated several POC cTn assays for imprecision, linearity, and correlation with central laboratory assays according to CLSI EP protocols. The linear regression analyses were performed only for the detectable concentrations. Five cTnI devices (Alere Triage, BioMerieux Vidas, Mitsubishi Pathfast, ReLIA TZ‐301, and Radiometer AQT90) were evaluated against a contemporary cTnI assay (Beckman Access II Accu TnI). Two cTnT assays (Radiometer AQT90 and Roche Cobas h232) were compared to a high‐sensitivity (hs) cTnT method (Roche Cobas e601). RESULTS: For cTn levels around the 99th percentile upper reference limits (URLs) of the comparator assays, imprecision could not be assessed for the Alere, BioMerieux, and Cobas h232 as they gave undetectable readings due to a lack of assay sensitivity. Imprecision (CV) was unacceptably high for the ReLIA (33.3%). On account of this precision metric, these four assays were deemed unsuitable. Regression analyses showed acceptable linearity for all the POC devices. The correlation coefficients for ReLIA, BioMerieux, Cobas h232, and Radiometer cTnT were >0.95. Unlike the cTnT devices, the cTnI assays employ different capture and detection antibodies leading to non‐commutable results. The POC cTn results were concordant with their comparator—Radiometer cTnT 90%, Pathfast cTnI 85%, and Radiometer cTnI 75%. CONCLUSION: Our study provides the procedure and essential data to guide selection of a POC cTn device. Of the point‐of‐care devices, methods evaluated Radiometer AQT90 (cTnI and cTnT) and Pathfast might be considered. John Wiley and Sons Inc. 2020-03-28 /pmc/articles/PMC7370753/ /pubmed/32222055 http://dx.doi.org/10.1002/jcla.23263 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Lin, Ya‐hui Zhang, Yang Liu, Yu‐tao Cui, Kai Kang, Jin‐suo Zhou, Zhou How to choose a point‐of‐care testing for troponin |
title | How to choose a point‐of‐care testing for troponin |
title_full | How to choose a point‐of‐care testing for troponin |
title_fullStr | How to choose a point‐of‐care testing for troponin |
title_full_unstemmed | How to choose a point‐of‐care testing for troponin |
title_short | How to choose a point‐of‐care testing for troponin |
title_sort | how to choose a point‐of‐care testing for troponin |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370753/ https://www.ncbi.nlm.nih.gov/pubmed/32222055 http://dx.doi.org/10.1002/jcla.23263 |
work_keys_str_mv | AT linyahui howtochooseapointofcaretestingfortroponin AT zhangyang howtochooseapointofcaretestingfortroponin AT liuyutao howtochooseapointofcaretestingfortroponin AT cuikai howtochooseapointofcaretestingfortroponin AT kangjinsuo howtochooseapointofcaretestingfortroponin AT zhouzhou howtochooseapointofcaretestingfortroponin |